tetano
Editor, Senior Moderator
BMC Infect Dis
. 2024 Aug 9;24(1):809.
doi: 10.1186/s12879-024-09652-y. Immune and inflammation features of severe and critical Omicron infected patients during Omicron wave in China
Yongmei Liu[SUP] #[/SUP][SUP] 1 [/SUP], Yaping Guo[SUP] #[/SUP][SUP] 2 [/SUP], Haoting Zhan[SUP] #[/SUP][SUP] 1 [/SUP], Xin Liu[SUP] #[/SUP][SUP] 2 [/SUP], Xiaomeng Li[SUP] 1 3 [/SUP], Jingjing Cui[SUP] 2 [/SUP], Haolong Li[SUP] 1 [/SUP], Sha Feng[SUP] 2 [/SUP], Linlin Cheng[SUP] 1 [/SUP], Xiaoyan Li[SUP] 2 [/SUP], Shuqin Guo[SUP] 4 [/SUP], Yongzhe Li[SUP] 5 [/SUP]
Affiliations
Objective: The current study aimed to investigate the baseline immune and inflammatory features and in-hospital outcomes of patients infected with the Omicron variant (PIWO) who presented with different disease severities during the first wave of mass Omicron infections in the Chinese population has occurred.
Method: A cross-sectional study was conducted on 140 hospitalized PIWO between December 11, 2022, and February 16, 2023. The clinical features, antibodies against SARS-CoV-2, immune cells, and inflammatory cytokines among mildly, severely, and critically ill PIWO at baseline and during follow-up period were compared.
Result: Patients with severe (n = 49) and critical (n = 35) disease were primarily male, needed invasive mechanical ventilation treatment, and exhibited higher mortality than those with mild disease (n = 56). During acute infection, SARS-CoV-2-specific antibody levels fluctuated with disease severity, serum antibodies increased and the incidence of severe cases decreased in critically ill PIWO over time. Antibody titers in severe or critical PIWO with no antibody responses at baseline did not increase significantly over time. Meanwhile, CD4[SUP]+[/SUP]T cell, CD8[SUP]+[/SUP]T cell, and natural killer cell counts were negatively correlated with disease severity, whereas interleukin (IL)-6 and IL-10 levels were positively correlated. In addition, combined diabetes, immunosuppressive therapy before infection, serum amyloid A, IL-10 and neutrophil counts were independently associated with severe and critical illness in PIWO. Among the 11 nonsurvivors, 8, 2, 1 died of respiratory failure, sudden cardiac death, and renal failure, respectively. Compared with survivors, nonsurvivors exhibited lower seropositivity of SARS-CoV-2-specific antibody, reduced CD3[SUP]+[/SUP]T and CD4[SUP]+[/SUP]T cell counts, and higher IL-2R, IL-6, IL-8, and IL-10 levels. Of note, lactate dehydrogenase was a significant risk factor of death in severe or critically ill PIWO.
Conclusion: This present study assessed the dynamic changes of SARS-CoV-2-specific antibodies, immune cells and inflammatory indexes between severely and critically ill PIWO. Critical and dead PIWO featured compromised humoral immune response and excessive inflammation, which broadened the understanding of the pathophysiology of Omicron infection and provides warning markers for severe disease and poor prognosis.
Keywords: Immune and inflammatory features; Mortality; Omicron variant infection; Risk factor; SARS-CoV-2; Severe and critical illness.
. 2024 Aug 9;24(1):809.
doi: 10.1186/s12879-024-09652-y. Immune and inflammation features of severe and critical Omicron infected patients during Omicron wave in China
Yongmei Liu[SUP] #[/SUP][SUP] 1 [/SUP], Yaping Guo[SUP] #[/SUP][SUP] 2 [/SUP], Haoting Zhan[SUP] #[/SUP][SUP] 1 [/SUP], Xin Liu[SUP] #[/SUP][SUP] 2 [/SUP], Xiaomeng Li[SUP] 1 3 [/SUP], Jingjing Cui[SUP] 2 [/SUP], Haolong Li[SUP] 1 [/SUP], Sha Feng[SUP] 2 [/SUP], Linlin Cheng[SUP] 1 [/SUP], Xiaoyan Li[SUP] 2 [/SUP], Shuqin Guo[SUP] 4 [/SUP], Yongzhe Li[SUP] 5 [/SUP]
Affiliations
- PMID: 39123106
- PMCID: PMC11316362
- DOI: 10.1186/s12879-024-09652-y
Objective: The current study aimed to investigate the baseline immune and inflammatory features and in-hospital outcomes of patients infected with the Omicron variant (PIWO) who presented with different disease severities during the first wave of mass Omicron infections in the Chinese population has occurred.
Method: A cross-sectional study was conducted on 140 hospitalized PIWO between December 11, 2022, and February 16, 2023. The clinical features, antibodies against SARS-CoV-2, immune cells, and inflammatory cytokines among mildly, severely, and critically ill PIWO at baseline and during follow-up period were compared.
Result: Patients with severe (n = 49) and critical (n = 35) disease were primarily male, needed invasive mechanical ventilation treatment, and exhibited higher mortality than those with mild disease (n = 56). During acute infection, SARS-CoV-2-specific antibody levels fluctuated with disease severity, serum antibodies increased and the incidence of severe cases decreased in critically ill PIWO over time. Antibody titers in severe or critical PIWO with no antibody responses at baseline did not increase significantly over time. Meanwhile, CD4[SUP]+[/SUP]T cell, CD8[SUP]+[/SUP]T cell, and natural killer cell counts were negatively correlated with disease severity, whereas interleukin (IL)-6 and IL-10 levels were positively correlated. In addition, combined diabetes, immunosuppressive therapy before infection, serum amyloid A, IL-10 and neutrophil counts were independently associated with severe and critical illness in PIWO. Among the 11 nonsurvivors, 8, 2, 1 died of respiratory failure, sudden cardiac death, and renal failure, respectively. Compared with survivors, nonsurvivors exhibited lower seropositivity of SARS-CoV-2-specific antibody, reduced CD3[SUP]+[/SUP]T and CD4[SUP]+[/SUP]T cell counts, and higher IL-2R, IL-6, IL-8, and IL-10 levels. Of note, lactate dehydrogenase was a significant risk factor of death in severe or critically ill PIWO.
Conclusion: This present study assessed the dynamic changes of SARS-CoV-2-specific antibodies, immune cells and inflammatory indexes between severely and critically ill PIWO. Critical and dead PIWO featured compromised humoral immune response and excessive inflammation, which broadened the understanding of the pathophysiology of Omicron infection and provides warning markers for severe disease and poor prognosis.
Keywords: Immune and inflammatory features; Mortality; Omicron variant infection; Risk factor; SARS-CoV-2; Severe and critical illness.